|
Product class:
|
Authorized package
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Package code:
|
1778014
|
|
Name of medicinal product:
|
Apravet
|
|
Active substances:
|
|
|
ATC code:
|
QA07AA92
|
|
Dosage form:
|
powder for use in drinking water/milk
|
|
Route of administration:
|
in drinking water/milk use
|
|
Strengh:
|
552RÜ 1mg
|
|
Amount in package:
|
1000000RÜ 50TK
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Class of active substance:
|
|
|
Additional information:
|
|
|
Indication:
|
Pigs (weaned piglets):
Treatment of bacterial enteritis caused by Escherichia coli susceptible to apramycin.
Pre-ruminant calves:
Treatment of bacterial enteritis caused by Escherichia coli and clinical outbreaks due to Salmonella enterica subsp. enterica serovar Dublin (Salmonella Dublin) susceptible to apramycin. Treatment should be based on prior confirmation of the Salmonella serovars involved or at least the availability of epidemiological data confirming the presence of this serovar.
Chickens:
Treatment of colibacillosis caused by Escherichia coli susceptible to apramycin.
Rabbits:
Treatment and metaphylaxis of bacterial enteritis caused by Escherichia coli susceptible to apramycin.
The presence of the disease in the herd must be established before the product is used.
|
|
Safety features:
|
No
|
|
Summary of product characteristics (SPC):
|
 (last updated October 9, 2018)
|
|
Package information leaflet (PIL):
|
EST (last updated October 9, 2018)
|
|
Labelling:
|
(last updated October 9, 2018)
|
|
Withdrawal time:
|
Siga:
Lihale ja söödavatele kudedele: 0 päeva.
Vasikas:
Lihale ja söödavatele kudedele: 28 päeva.
Kana:
Lihale ja söödavatele kudedele: 0 päeva.
Mitte kasutada lindudel, kelle mune tarvitatakse või kavatsetakse tarvitada inimtoiduks. Mitte kasutada 4 nädala jooksul enne munemisperioodi algust.
Küülik:
Lihale ja söödavatele kudedele: 0 päeva.
|
|
Species:
|
veis (vasikas), siga, kana, küülik
|
|
Last imported to Estonia:
|
Never imported to Estonia
|
|
Marketing authorization holder:
|
Huvepharma
|
|
Marketing authorization number:
|
2114
|
|
Marketing authorization issued on:
|
October 9, 2018
|
|
Marketing authorization expires on:
|
October 9, 2023
|
|
Marketing authorization procedure type:
|
Decentralised
|
Entry/Changing date:
May 19, 2022
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere